文献速递乳腺癌

既往临床乳腺检查与秘鲁女性乳腺癌诊断延迟减少及分期提前的关联

Association of Previous Clinical Breast Examination With Reduced Delays and Earlier-Stage Breast Cancer Diagnosis Among Women in Peru.
PubMed 文献 · JAMA Oncol · 2017-01-01

该横断面研究纳入秘鲁特鲁希略一家联邦资助三级转诊癌症中心2015年2月1日至5月31日治疗的159例乳腺癌女性中的113例(71.1%),分析既往临床乳腺检查与就诊时间及诊断分期的关联。结果显示,既往临床乳腺检查与患者延迟缩短(OR 2.92,95%CI 1.30-6.60,P=0.01)及早期诊断(校正后OR 2.44,95%CI 1.01-5.95,P=0.048)相关。

要点

  • 113例中105例(92.9%)为自检发现,93例有分期记录者中早期(AJCC 0、I、II期)占48.4%。
  • 从症状出现到开始治疗的平均总延迟为407(665)天,其中患者延迟平均198(449)天。
  • 既往临床乳腺检查与患者延迟缩短及早期诊断相关(校正后OR 2.44,95%CI 1.01-5.95)。

核心结论

  • 在大多数乳腺癌为自检发现的人群中,既往临床乳腺检查与患者延迟缩短及乳腺癌诊断分期提前相关。
  • 在缺乏乳腺X线筛查的地区,常规临床乳腺检查可能提供适合当地资源的改善乳腺癌早期诊断的策略。

研究设计与样本

  • 采用经验证的乳腺癌延迟问卷进行个体患者访谈的横断面分析。
  • 2015年2月1日至5月31日在秘鲁特鲁希略一家联邦资助三级转诊癌症中心治疗的159例乳腺癌女性中,113例(71.1%)被纳入研究。

主要发现

  • 113例确诊癌症女性平均(SD)年龄54(10.8)岁,年龄范围32-82岁;105例(92.9%)为自检发现。
  • 93例有分期记录的女性中,45例(48.4%)诊断为早期(AJCC 0、I或II期),48例(51.6%)诊断为晚期(AJCC III或IV期)。
  • 从症状出现到开始治疗的平均(SD)总延迟为407(665)天,患者延迟平均(SD)198(449)天,卫生系统延迟平均(SD)241(556)天。
  • 52例(46.0%)有临床乳腺检查史,23例(20.4%)既往接受过乳腺X线检查。
  • 既往接受临床乳腺检查的女性较从未接受者更可能从症状出现到就诊的延迟更短(OR 2.92,95%CI 1.30-6.60,P=0.01)。

关键数值与推荐

  • 既往临床乳腺检查与患者延迟缩短的OR为2.92(95%CI 1.30-6.60,P=0.01)。
  • 既往临床乳腺检查与早期诊断的校正OR为2.44(95%CI 1.01-5.95,P=0.048),校正因素为保险和家庭收入。
  • 患者延迟较短组早期诊断比例为58.5%(31例),延迟较长组为30.6%(11例),P=0.01。

临床怎么用

  • 在缺乏乳腺X线筛查的地区,常规临床乳腺检查可能提供适合当地资源的改善乳腺癌早期诊断的策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Mammographic screening is impractical in most of the world where breast cancers are first identified based on clinical signs and symptoms. Clinical breast examination may improve early diagnosis directly by finding breast cancers at earlier stages or indirectly by heightening women's awareness of breast health concerns. OBJECTIVE: To investigate factors that influence time to presentation and stage at diagnosis among patients with breast cancer to determine whether history of previous clinical breast examination is associated with earlier presentation and/or earlier cancer stage at diagnosis. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional analysis of individual patient interviews using a validated Breast Cancer Delay Questionnaire, 113 (71.1%) of 159 women with breast cancer treated at a federally funded tertiary care referral cancer center in Trujillo, Peru, from February 1 through May 31, 2015, were studied. MAIN OUTCOMES AND MEASURES: Method of breast cancer detection and factors that influence time to and stage at diagnosis. RESULTS: Of 113 women with diagnosed cancer (mean [SD] age, 54 [10.8] years; age range, 32-82 years), 105 (92.9%) had self-detected disease. Of the 93 women for whom stage was documented, 45 (48.4%) were diagnosed with early-stage disease (American Joint Committee on Cancer [AJCC] stage 0, I, or II), and 48 (51.6%) were diagnosed with late-stage disease (AJCC stage III or IV). Mean (SD) total delay from symptom onset to initiation of treatment was 407 (665) days because of patient (mean [SD], 198 [449] days) and health care system (mean [SD], 241 [556] days) delay. Fifty-two women (46.0%) had a history of clinical breast examination, and 23 (20.4%) had undergone previous mammography. Women who underwent a previous clinical breast examination were more likely to have shorter delays from symptom development to presentation compared with women who had never undergone a previous clinical breast examination (odds ratio, 2.92; 95% CI, 1.30-6.60; P = .01). Women diagnosed with shorter patient delay were more likely to be diagnosed with early-stage disease (AJCC stage 0, I, or II) than those with longer patient delay (31 [58.5%] vs 11 [30.6%], P = .01). Women who underwent a previous clinical breast examination were more likely to be diagnosed with early-stage disease compared with women who had never undergone previous clinical breast examination; this relationship remained significant after controlling for insurance and household income (odds ratio, 2.44; 95% CI, 1.01-5.95; P = .048). CONCLUSIONS AND RELEVANCE: In a population in which most breast cancers are self-detected, previous clinical breast examination was associated with shorter patient delay and earlier stage at breast cancer diagnosis. In regions of the world that lack mammographic screening, the routine use of clinical breast examination may provide a resource-appropriate strategy for improving breast cancer early diagnosis.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Romanoff A, Constant TH, Johnson KM, et al. Association of Previous Clinical Breast Examination With Reduced Delays and Earlier-Stage Breast Cancer Diagnosis Among Women in Peru. JAMA Oncol. 2017. PMID: 28542677. doi:10.1001/jamaoncol.2017.1023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。